- 110208台北市信義區基隆路一段333號18樓1806室
- Taiwania Capital Management USA, Inc 3945 Freedom Circle, Suite 760, Santa Clara, CA 95054
Portfolio
Updated：
1.AESOP (Fund III)
AESOP stands for AI-enhanced Safety of Physicians and can make physician clinical documentation easier, faster, and less error-prone using Machine Learning on 3.2 billion patient visits.
2.AEye (Fund I)
Delivering human perception for autonomous vehicles.
3.AIxMed (Fund III)
Powered by AI, addresses unique challenges in cytology slide digitization, image analysis, and workflow optimization.
4.Ambiq Micro (Fund I)
Ultra-low power MCUs for wearable and IoT devices.
5.AmMax Bio, Inc. (Fund II)
A clinical stage biotech company focused on unlocking the therapeutic potential of the CSF1R platform.
6.AnnJI Pharma (Fund II)
Small molecule drugs for dermatology and neurology.
7.Appaegis Inc.(Fund V)
Data Security, Control, Visibility and Malware Protection at Anytime from Anywhere.
8.Arris Composites (Fund I)
Revolutionizing the manufacturing process of carbon fiber composites.
9.Artilux (Fund I)
Pioneer in advanced GeSi photonic technology for wide spectrum 3D sensing and communication.
10.Atayalan(Fund I&V)
Atayalan focuses on delivering turn-key multi-radio access (5G/4G/WiFi) networking solution.
11.AVESHA(Fund I)
Application Aware Overlay Network for developing cloud applications easily in multi-cloud environment.
12.Bigfoot Biomedical (Fund II)
Developer of a diabetes management system for people living with insulin-requiring diabetes.
13. Canner (Fund V)
Canner focuses on solving data access workflow in enterprises and accelerating data-driven innovations at scale.
14.C4 Therapeutics (Fund II)
Destroying proteins that cause cancers, neurological, and other diseases.
15.Cognito Health Inc.(Fund I)
Predictive bed fall prevention and patient monitoring tool.
16.Dcard (Fund I)
The biggest mobile forum in Taiwan with millions of active users.
17.DSP Concepts (Fund I)
The ultimate solution provider for audio DSP.
18.EirGenix (Fund II)
Making biosimilars affordable and accessible to patients everywhere.
19.ELIXIRON (Fund II)
Unique Immunotherapies for presently untreatable cancers and chronic hepatitis B.
20.Ethernovia (Fund I&V)
Ethernovia is virtualizing vehicle communication to enable the software defined vehicle.
21.FaceHeart (Fund III)
FaceHeart Corp. improves human health through its proprietary video-based rPPG solutions.
22.FIGUR8 (Fund I)
A platform that accurately digitizes and analyzes musculoskeletal (MSK) health.
23.FRACTYL (Fund II)
Leveraging intestinal biology to transform the treatment of metabolic diseases.
24.Frequency Therapeutics (Fund II)
Activating the body’s innate healing ability to treat degenerative diseases.
25.Handa Pharma (Fund II)
Niche new drugs and high barrier/patentable products.
26.Health 2 Sync (Fund III)
H2Sync aims to provide cloud-based personalized, scalable digital solutions for chronic disease patients to help users improve chronic disease management.
27.KDAN Mobile (Fund I)
A global SaaS provider such as an e-signature service and different productivity and creativity-related tools.
28.LANDING AI (Fund I)
Helping companies jumpstart AI adoption and create real business value today.
29.LIGHT FIELD LAB (Fund I)
Real holograms without the need of headgears.
30.Metanoia Communications Inc. (Fund I)
RF IC and Baseband IC for 5G and 5G O-Ran application
31.Nanolive (Fund II)
Nanolive offers a revolutionary non-invasive label-free live cell imaging platform, combined with a proprietary AI-assisted analytical, optimized for drug discovery and biomedical research.
32.OCULii (Fund I)
Breakthrough 4D radar imaging for autonomous systems.
33.Pavilion Data Systems (Fund I)
High performance storage solution for enterprises.
34.PharmaEssentia (Fund II)
Novel treatments for myeloproliferative neoplasms (MPNs), hepatitis, and cancers.
35.Point Robotics MedTec (Fund II)
Advanced robotics that makes spinal surgeries safer than ever.
36.Regenacy Pharmaceuticals (Fund II)
Restoring nerve function to treat diabetic and other peripheral neuropathies.
37. SafeLiShare (Fund V)
SafeLiShare enables safe usage & sharing of sensitive assets for enterprises in the multi-cloud, powered by confidential computing.
38.Suono Bio (Fund II)
Suono Bio is developing therapeutic products for inflammatory-mediated diseases leveraging their ultra-rapid and formulation independent delivery technology.
39.SyneuRx (Fund II)
The goal is to develop revolutionary, new drugs for mental/behavioral health, including schizophrenia, dementia, depression, and COVID-19.
40. Tantti (Fund V)
Developing innovative biomaterials technology to provide transformative solutions to biopharma supply chains, including production of vaccines, stem cells and gene therapies.
41. TFBS Bioscience Inc. (Fund II)
The first contract research organization in Taiwan that focuses on biological safety and quality testing and provides GMP grade viral vector CDMO service for the emerging cell/gene therapy market.
42. 3nets.io (Fund I&V)
Next generation networking design.
43.Touché Solutions (Fund I)
Empowering human-machine collaboration through touch.
44.TRICORNTECH (Fund I)
Laboratory-grade VoC detectors for real time monitoring.
45Tripresso (Fund I)
An e-commerce travel platform providing B2C and B2B users with a great travel and management experience.
46.Ubiik (Fund I)
Distinguished innovator in the IoT system, including hardware, wireless connectivity, embedded software and cloud platform.
47.URSROBOT (Fund V)
URSROBOT is a team of builders, thinkers who design service robots that make life smarter. "Let service robot be part of everyone's life" is our goal.
48.Verana Networks(Fund V)
Providing a mmWave 5G network solution can reduce the cost to 1/10 compared to current suppliers to expedite mmWave 5G deployment.
49.Windgap Medical Inc. (Fund II)
Innovative autoinjector platform that provides simple-to-use, safe, and stable performance enables development and impact of difficult-to-stabilize drugs.
51.XGene (Fund II)
Small molecule drugs for acute pain, chronic pain and infectious diseases.